Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Stanton

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
The Journal of General Virology|March 22, 2007
Adenovirus vector delivery stimulates natural killer cell recognitionPeter Tomasec, Eddie C Y Wang, Veronika Groh, et al.
The Journal of General Virology|April 30, 2024
HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2LLeah M Hunter, Joanne Kite, Alice Fletcher-Etherington, et al.
The Journal of Biological Chemistry|September 11, 2024
Impaired endocytosis and accumulation in early endosomal compartments defines herpes simplex virus-mediated disruption of the nonclassical MHC class I-related molecule MR1Carolyn Samer, Hamish E G McWilliam, Brian P McSharry, et al.
Plos Pathogens|December 17, 2011
The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cellsIldar Gabaev, Lars Steinbrück, Claudia Pokoyski, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infectionEleanor C Semmes, Itzayana G Miller, Nicole Rodgers, et al.
JCI Insight|July 10, 2023
ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmissionEleanor C Semmes, Itzayana G Miller, Nicole Rodgers, et al.
The Journal of General Virology|April 23, 2010
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112Virginie Prod'homme, Daniel M Sugrue, Richard J Stanton, et al.
JCI Insight|June 20, 2023
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2Michael D Grant, Kirsten Bentley, Ceri A Fielding, et al.
Nature|June 5, 2024
A virally encoded high-resolution screen of cytomegalovirus dependenciesYaara Finkel, Aharon Nachshon, Einav Aharon, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
The Journal of General Virology|March 22, 2007
Adenovirus vector delivery stimulates natural killer cell recognitionPeter Tomasec, Eddie C Y Wang, Veronika Groh, et al.
The Journal of General Virology|April 30, 2024
HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2LLeah M Hunter, Joanne Kite, Alice Fletcher-Etherington, et al.
The Journal of Biological Chemistry|September 11, 2024
Impaired endocytosis and accumulation in early endosomal compartments defines herpes simplex virus-mediated disruption of the nonclassical MHC class I-related molecule MR1Carolyn Samer, Hamish E G McWilliam, Brian P McSharry, et al.
Plos Pathogens|December 17, 2011
The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cellsIldar Gabaev, Lars Steinbrück, Claudia Pokoyski, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infectionEleanor C Semmes, Itzayana G Miller, Nicole Rodgers, et al.
JCI Insight|July 10, 2023
ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmissionEleanor C Semmes, Itzayana G Miller, Nicole Rodgers, et al.
The Journal of General Virology|April 23, 2010
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112Virginie Prod'homme, Daniel M Sugrue, Richard J Stanton, et al.
JCI Insight|June 20, 2023
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2Michael D Grant, Kirsten Bentley, Ceri A Fielding, et al.
Nature|June 5, 2024
A virally encoded high-resolution screen of cytomegalovirus dependenciesYaara Finkel, Aharon Nachshon, Einav Aharon, et al.
Pageof 8